Results 111 to 120 of about 24,646 (191)

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

Background: the combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We therefore assessed whether fondaparinux would
Esplugas Oliveras, Enrique, The OASIS-5 committee   +1 more
core  

Comparative effectiveness of parenteral anticoagulants (fondaparinux, argatroban, bivalirudin) in heparin-induced thrombocytopenia: A systematic review. [PDF]

World J Methodol
Rehman A, Abid M, Jamil H, Siddique S, Parkash S, Nasrullah F, Sapna F, Lohana B, Lohana K, Jawed I, Tufail M, Sharaf MS.   +11 more
europepmc   +1 more source

Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill

, 2007
Background: In critically ill patients, heparin-induced thrombocytopenia (HIT) is estimated to account for approximately 1 to 10% of all causes of thrombocytopenia. HIT exerts a strong procoagulant state.
Wester, J. P J, Oudemans-van Straaten, H. M., Zandstra, D. F., Porcelijn, L., Bosman, R. J., Haak, E. A F, Van der Spoel, J. I., Leyte, A.   +7 more
core  

Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system. [PDF]

PLoS One
Kang F, Wang Y, Cai F, Wu L, Han L, Yin Q, Bian Y.   +6 more
europepmc   +1 more source

Adverse event profile of fondaparinux sodium: a disproportionality analysis based on FAERS, JADER, and VigiAccess databases. [PDF]

Front Med (Lausanne)
Jin W, Pan J, Yu L, Zhu M.
europepmc   +1 more source

Anticoagulation for Cancer Patients in Special Situations: A Narrative Review of Guidelines and Literature. [PDF]

Cancers (Basel)
Sotoca Rubio P, Serrano Domingo JJ, Guerrero Serrano P, Pérez de Aguado Rodríguez P, Barrill Corpa AM, Moreno Doval J, García de Quevedo Suero C, Calvo Pérez JC, González-Merino C, González Martín G, Chamorro Pérez J, Gómez Rueda A, Garrido López P.   +12 more
europepmc   +1 more source

Safety Profile and Bleeding Complications of Fondaparinux Versus Enoxaparin in Non-ST Elevation Acute Coronary Syndrome. [PDF]

Cureus
Rahman MM, Ahmed FU, Chowdhury MI, Noor H, Hossain MA.   +4 more
europepmc   +1 more source

Safety of Fondaparinux After Low-Molecular-Weight Heparin in Bleeding-Complicated High-Risk Pregnancies: A PSM Cohort Study. [PDF]

Int J Womens Health
Yang H, Gao Y, Song X.
europepmc   +1 more source

Fondaparinux [PDF]

, 2019
openaire   +1 more source

Heparin-induced Thrombocytopenia Successfully Treated With Fondaparinux

, 2009
We report the successful treatment of a patient with HIT-associated venous thrombosis by fondaparinux, a synthetic pentasaccharide. Although not yet approved for this indication, this new anticoagulant may be a useful alternative in the setting of ...
Seldrum, Stéphanie, Lambert, Michel, Hainaut, Philippe   +2 more
core